Cargando…

Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA

The characteristics of IDH-wild-type lower-grade astrocytoma remain unclear. According to cIMPACT-NOW update 3, IDH-wild-type astrocytomas with any of the following factors show poor prognosis: combination of chromosome 7 gain and 10 loss (+ 7/− 10), and/or EGFR amplification, and/or TERT promoter (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makino, Yasuhide, Arakawa, Yoshiki, Yoshioka, Ema, Shofuda, Tomoko, Kawauchi, Takeshi, Terada, Yukinori, Tanji, Masahiro, Kanematsu, Daisuke, Mineharu, Yohei, Miyamoto, Susumu, Kanemura, Yonehiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277860/ https://www.ncbi.nlm.nih.gov/pubmed/34257410 http://dx.doi.org/10.1038/s41598-021-93937-8

Ejemplares similares

LGG-38. GENETIC ANALYSIS OF NEUROEPITHELIAL TUMORS IN THE PEDIATRIC AND ADOLESCENT AND YOUNG ADULT AGE IN A SINGLE INSTITUTE
por: Makino, Yasuhide, et al.
Publicado: (2020)

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
por: Makino, Yasuhide, et al.
Publicado: (2021)

NI-02 THE ASSOCIATION BETWEEN (11)C-METHIONINE UPTAKE, IDH GENE MUTATION, AND MGMT PROMOTER METHYLATION IN PATIENTS WITH GRADE II AND III GLIOMAS
por: Okita, Yoshiko, et al.
Publicado: (2019)

Malignant transformation of central neurocytoma with dissemination 17 years after initial treatment: illustrative case
por: Kojima, Kazuhiro, et al.
Publicado: (2022)

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

COT-07 Cerebrovascular complications in adult patients with malignant brain tumor
por: Mineharu, Yohei, et al.
Publicado: (2020)

TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma
por: Kikuchi, Zensho, et al.
Publicado: (2020)

T(2)-FLAIR Mismatch Sign Is Caused by Long T(1) and T(2) of IDH-mutant, 1p19q Non-codeleted Astrocytoma
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses
por: Herman, Sandra, et al.
Publicado: (2012)

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts
por: Umehara, Toru, et al.
Publicado: (2019)

COT-13 Current situation and problems of cancer genomic profiling test in Kyoto University Hospital
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

Ipsilateral hemiparesis caused by putaminal hemorrhage in a patient with horizontal gaze palsy with progressive scoliosis: a case report
por: Yamada, Shuhei, et al.
Publicado: (2015)

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas
por: Arita, Hideyuki, et al.
Publicado: (2018)

Papillary glioneuronal tumor growing slowly for 26 years: illustrative case
por: Shinno, Kazuma, et al.
Publicado: (2021)

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2023)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Prenatal diagnosis of 1408 foetuses at risk of DMD/BMD by MLPA and Sanger sequencing combined with STR linkage analysis
por: Hua, Chunxiao, et al.
Publicado: (2023)

Feeder-Free Generation and Long-Term Culture of Human Induced Pluripotent Stem Cells Using Pericellular Matrix of Decidua Derived Mesenchymal Cells
por: Fukusumi, Hayato, et al.
Publicado: (2013)

COT-12 The role of clinical research professional in the registration study of pediatric solid tumor in Japan Children’s Cancer Group
por: Furukawa, Keiko, et al.
Publicado: (2020)

Central nervous system mature teratoma producing carbohydrate antigen 19-9: illustrative case
por: Takeuchi, Shu, et al.
Publicado: (2022)

MBRS-38. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF 236 MEDULLOBLASTOMAS IN JAPAN
por: Kanemura, Yonehiro, et al.
Publicado: (2020)

Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network
por: Fukuma, Ryohei, et al.
Publicado: (2019)

TB-01 HUMAN IPS CELL-DERIVED BRAIN TUMOR MODEL UNCOVERS THE EMBRYONIC STEM CELL SIGNATURE AS A KEY DRIVER IN ATYPICAL TERATOID/RHABDOID TUMOR
por: Terada, Yukinori, et al.
Publicado: (2019)

Small-scale screening of anticancer drugs acting specifically on neural stem/progenitor cells derived from human-induced pluripotent stem cells using a time-course cytotoxicity test
por: Fukusumi, Hayato, et al.
Publicado: (2018)

Malignant Progression of an IDH Mutant Brainstem Glioma in Adult
por: SANO, Kenshi, et al.
Publicado: (2021)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases
por: TAKEUCHI, Hayato, et al.
Publicado: (2022)

Mixed germ cell tumor infiltrating the pineal gland without elevated tumor markers: illustrative case
por: Shiomi, Koji, et al.
Publicado: (2021)

COT-11 EFFECT OF PHYSICIAN SUPPORTS ON QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL BRAIN TUMOR RESEARCH
por: Furukawa, Keiko, et al.
Publicado: (2019)

MPC-04 MOLECULAR FEATURES AND CLINICAL OUTCOMES OF ELDERLY GLIOBLASTOMA PATIENTS: ANALYSES OF KANSAI NETWORK AND TCGA COHORTS
por: Fukai, Junya, et al.
Publicado: (2019)

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience
por: Cho, Uiju, et al.
Publicado: (2021)

PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes
por: Liu, Bin, et al.
Publicado: (2018)

Rare Cases of IDH1 Mutations in Spinal Cord Astrocytomas
por: Konovalov, N. A., et al.
Publicado: (2020)

Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins
por: Fukusumi, Hayato, et al.
Publicado: (2016)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Generation of Induced Pluripotent Stem Cells and Neural Stem/Progenitor Cells from Newborns with Spina Bifida Aperta
por: Bamba, Yohei, et al.
Publicado: (2017)

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma
por: Sabunga, Olivia Desty, et al.
Publicado: (2022)

LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
por: da Silva, Roseli, et al.
Publicado: (2015)

Intra-cerebellar schwannoma with various degenerative changes: a case report and a systematic review
por: Takeuchi, Yasuhide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kuvons8b41qejm5cbtkqvq8rpp